Skip to main content

Poster Abstracts

  • Chapter
  • 48 Accesses

Abstract

This series of short communications presents, in miniature, the diversity of applications which exists for scintigraphic studies in drug formulation. It may be classified into three main groups reflecting the three major divisions seen when considering the subject as a whole. In the first group, representing the field most closely akin to nuclear medicine, radionuclide tracers are used to demonstrate the progress of pathological conditions, or to show the response of these conditions to various therapeutic regimes. The second group uses radionuclides to demonstrate physiological or metabolic processes. Again it is possible to extend this group to include an assessment of the response of these processes to drug therapy. Thirdly, there is the group of studies in which radionuclides are incorporated as an integral part of the drug formulation; allowing the fate of the formulation to be monitored externally.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Clark J C, Buckingham P D (1975) Short-Lived Radioactive Gases for Clinical Use, Butterworths, London

    Google Scholar 

  • Rose I A, Gunberg-Manago M, Korey S R, Ochoa S (1954) Enzymatic phosphorylation of acetate, J. Biol. Chem. 211: 737–756

    Google Scholar 

  • Bishop H M, Blarney R W, Morris A H, Rose D H, Preston B, Lane J, Doyle P J (1979) Bone scanning: its lack of value in the follow-up of patients with breast cancer, Br. J. Surg. 66: 752–754

    Article  Google Scholar 

  • Alpsten M, Ekenved G, Sülvell (1976) A profile scanning method of studying the release properties of different types of tablets in man, Acta Pharm. Suec. 13: 107–122

    Google Scholar 

  • Bechgaard H, Ladefoged K (1978) Distribution of pellets in the gastrointestinal tract. The influence on transit time exerted by the density or diameter of pellets, J. Pharm. Pharmacol. 30: 690–692

    Article  Google Scholar 

  • Rahman Y, Rosenthal MW (1973) A new approach to the therapy of metal poisoning: liposome encapsulation of chelating agents, Radiat. Res. 55: 516–517

    Google Scholar 

  • Rahman Y-E, Rosenthal M W, Cerny E A (1973) Intracellular plutonium: removal by liposome encapsulated chelating agent, Science 180: 300–302

    Article  Google Scholar 

  • Rosenthal M W, Rahman Y E, Moretti E S, Cerny E A (1975) Removal of polymeric plutonium by DTPA directed into cells by liposome encapsulation, Radiat. Res. 63: 262–274

    Article  Google Scholar 

  • Bullingham R E S, McQuay H J, Dwyer D, Allen M C, Moore R A (1981) Sublingual buprenorphine used post-operatively: clinical observations and patient pharmacokinetic analysis, Br. J. Clin. Pharmacol, (in press)

    Google Scholar 

  • Edge W G, Cooper G M, Morgan M (1979) Analgesic effects of sublingual buprenorphine, Anaesthesia 34: 463–467

    Article  Google Scholar 

  • Houde R W, Wallenstein S L, Beaver W T (1965) in: deStevens G (ed) Analgetics, Academic Press, New York, pp75–122

    Google Scholar 

  • Iwamoto K, Klaassen C D (1977) First-pass effect of morphine in rats, J. Pharmacol. Exp. Ther. 200: 236–244

    Google Scholar 

  • Jasinski D R, Pevnick J S, Griffith J D (1978) Human pharmacology and abuse potential of the analgesic buprenorphine. A potential agent for treating narcotic addiction, Arch. Gen. Psychiatry 35: 501–516

    Article  Google Scholar 

  • Kay B (1978) A double-blind comparison of morphine and buprenorphine in the prevention of pain after operation, Br. J. Anaesth. 50: 605–609

    Article  Google Scholar 

  • Ranee M J, Shillingford J S (1977) The metabolism of phenolic opiates by rat intestine, Xenobiotica 7: 529–536

    Article  Google Scholar 

  • Robbie D S (1979) A trial of sublingual buprenorphine in cancer pain, Br. J. Clin. Pharmacol. 7 (Supplement 3): 315S-317S

    Google Scholar 

  • Arrowsmith M, Hadgraft J, Kellaway I W (1980) The formulation of cortisone esters in liposomes, J. Pharm. Pharmacol. 32 (Supplement): 60P

    Article  Google Scholar 

  • Lubran M, Pearson J D (1958) A screening test for steatorrhoea using 131I-labelled triolein, J. Clin. Pathol. 11: 165–169

    Article  Google Scholar 

  • McDougall I R, Dunnick J K, Goris M L, Kriss J P (1975) In vivo distribution of vesicles loaded with radiopharmaceuticals: a study of different routes of administration, J. Nucl. Med. 16: 488–491

    Google Scholar 

  • Wagner J G, Nelson E (1963) Per cent absorbed time plots derived from blood level and/or urinary excretion data, J. Pharm. Sci. 52: 610–611

    Article  Google Scholar 

  • Buckwalter F H, Dickison H L (1958) The effect of vehicle and particle size on the absorption, by the intramuscular route, of procaine penicillin G suspensions, J. Amer. Pharm. Ass. 47: 661–666

    Article  Google Scholar 

  • Huh Y, Donaldson G W, Johnston F J (1974) A radiation-induced bonding of iodine at the surface of uniform polystyrene particles, Radiât. Res. 60: 42–53

    Article  Google Scholar 

  • Kanke M, Simmons G H, Weiss D L, Bivins B A, DeLuca P P (1980) Clearance of 141Ce-labeled microspheres from blood and distribution in specific organs following intravenous and intraarterial administration in beagle dogs, J. Pharm. Sci. 69: 755–762

    Article  Google Scholar 

  • Tanaka T, Kobayashi H, Okumura K, Muranishi S, Sezaki H (1974) Intramuscular absorption of drugs from oily solutions in the rat, Chem. Pharm. Bull. 22: 1275–1284

    Article  Google Scholar 

  • Hagan P L, Krejcarek G E, Taylor A, Alazraki N (1978) A rapid method for the labeling of albumin microspheres with In-113 and In-111: concise communication, J. Nucl. Med. 19: 1055–1058

    Google Scholar 

  • Marty J J, Oppenheim R C (1977) Colloidal systems for drug delivery, Aust. J. Pharm. Sci. 6: 65–76

    Google Scholar 

  • Taplin G V, Johnson D E, Dore E K, Kaplan H S (1964) Suspensions of radioalbumin aggregates for photoscanning the liver, spleen, lung and other organs, J. Nucl. Med. 5: 259–275

    Google Scholar 

  • Wochner R D, Adatepe M, Van Amburg A, Potchen E J (1970) A new method for estimation of plasma volume with the use of the distribution space of indium-113m-transferrin, J. Lab. Clin. Med. 75: 711–720

    Google Scholar 

  • Zolle I, Rhodes B A, Wagner H N (1970) Preparation of metabolizable radioactive human serum albumin microspheres for studies of the circulation, Int. J. Appl. Radiat. Isot. 21: 155–167

    Article  Google Scholar 

  • Armstrong N A, James K C (1980) Drug release from lipid-based dosage forms. II, Int. J. Pharm. 6: 195–204

    Article  Google Scholar 

  • Hunt J N, Knox M T (1969) A relation between the chain length of fatty acids and the slowing of gastric emptying, J. Physiol. (Lond.) 194: 327–336

    Google Scholar 

  • Palin K, Davis S S, Phillips A J, Whalley D, Wilson C G (1980) Effect of lipid vesicles on the oral absorption of a model compound (DDT), J. Pharm. Pharmacol. 32 (Supplement): 62P

    Article  Google Scholar 

  • Palin K J, Davis S S, Phillips A J, Wilson C G (1981) The lymphatic absorption of a model compound (DDT), in: Proceedings of the First European Congress of Biopharmaceutics and Pharmacokinetics, Libraire Lavoisier, Paris (in press)

    Google Scholar 

  • Higuchi T (1963) Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices, J. Pharm. Sci. 52: 1145–1149

    Article  Google Scholar 

  • Bryan A J, Kaur R, Robinson G, Thomas N W, Wilson C G (1980) Histological and physiological studies on the intestine of the rat exposed to solutions of Myrj 52 and PEG 2000, Int. J. Pharm. 7: 145–156

    Article  Google Scholar 

  • Chang T M S (1972) Artificial Cells, Thomas, Springfield

    Google Scholar 

  • Chang T M S (1977) in: Chang T M S (ed) Biomedical Applications of Immobilized Enzymes and Proteins, Volume 1, Plenum Press, New York, pp69–90

    Chapter  Google Scholar 

  • Florence A T, Whateley T L, Wood D A (1979) Potentially biodegradable microcapsules with poly (alkyl 2-cyanoacrylate) membranes, J. Pharm. Pharmacol. 31: 422–424

    Article  Google Scholar 

  • Wood D A, Whateley T L, Florence A T (1979) Microencapsulation of histidase for enzyme replacement therapy, J. Pharm. Pharmacol. 31 (Supplement): 79P

    Article  Google Scholar 

  • Wood D A, Whateley T L, Florence A T (1981) Formation of poly(butyl 2-cyanoacrylate) microcapsules and the microencapsulation of aqueous solutions of (125I)-labelled proteins, Int. J. Pharm. 8: 35–43

    Article  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1982 C.G. Wilson, J.G. Hardy, M. Frier and S.S. Davis

About this chapter

Cite this chapter

Frier, M. (1982). Poster Abstracts. In: Wilson, C.G., Hardy, J.G., Frier, M., Davis, S.S. (eds) Radionuclide Imaging in Drug Research. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-9728-1_19

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-9728-1_19

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-011-9730-4

  • Online ISBN: 978-94-011-9728-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics